BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2008785)

  • 21. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
    Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
    Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
    [No Abstract]   [Full Text] [Related]  

  • 23. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
    Spaëth D; Geoffrois L; Conroy T
    Bull Cancer; 2000 Jan; 87(1):93-6. PubMed ID: 10673637
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute myeloic leukemia: evaluation of colony-stimulating factors].
    Hiddemann W
    Dtsch Med Wochenschr; 2012 Nov; 137(45):2306. PubMed ID: 23111791
    [No Abstract]   [Full Text] [Related]  

  • 26. [Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Gratwohl A; Dazzi H; Tichelli A; Stebler C; Wernli M; Thomssen C; Kim I; Dieterle A; Obrist R; Stern A
    Schweiz Med Wochenschr; 1991 Mar; 121(12):413-7. PubMed ID: 2028244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.
    Stull DM; Bilmes R; Kim H; Fichtl R
    Am J Health Syst Pharm; 2005 Jan; 62(1):83-7. PubMed ID: 15658078
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful short-term treatment with granulocyte-macrophage colony-stimulating factor of neutropenia due to cytotoxic chemotherapy of chronic lymphocytic leukemia.
    Rave K; Brittinger G
    Ann Hematol; 1991 Dec; 63(6):333. PubMed ID: 1756194
    [No Abstract]   [Full Text] [Related]  

  • 30. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic growth factors for chemotherapy-induced neutropenia.
    Yalçin S
    Cancer Invest; 1999; 17(7):555-6. PubMed ID: 10518202
    [No Abstract]   [Full Text] [Related]  

  • 32. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of hematopoietic growth factors G-CSF/GM-CSF in the treatment of neutropenia in children with acute lymphoblastic leukemia and non-Hodgkin's lymphomas].
    Nowak K; Pekacka K; Trelińska J; Stolarska M; Bodalski J
    Wiad Lek; 1998; 51 Suppl 4():237-42. PubMed ID: 10731975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
    Johnston EM; Crawford J
    Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autologous transplantation of hematopoietic stem cells and growth factors].
    Harousseau JL
    Pathol Biol (Paris); 1993 Jan; 41(1):50. PubMed ID: 7686287
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 37. Colony-stimulating factors for drug-induced neutropenia (other than antineoplastic- or HIV-associated).
    Tecnologica; 1995 May; ():9-10. PubMed ID: 10168291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of granulocyte colony-stimulating factor on granulopoiesis of congenital neutropenic children.
    Benkö I; Maródi L; Megyeri A; Káposzta R; Kovács P
    Acta Physiol Hung; 1996; 84(3):261-2. PubMed ID: 9219597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with antibiotics in the treatment of febrile neutropenia in children.
    Riikonen P
    Stem Cells; 1995 May; 13(3):201-5. PubMed ID: 7613488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth factors and empiric therapy with antibiotics: should they be used concurrently?
    Schimpff SC
    Ann Intern Med; 1994 Oct; 121(7):538-40. PubMed ID: 7520677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.